The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment

American Journal of Hematology

Volumn 90, Issue 4, 2015, Pages 306-309

  Poggiali, Erika ^a   Andreozzi, Fabio ^a   Nava, Isabella ^a   Consonni, Dario ^b   Graziadei, Giovanna ^a   Cappellini, Maria Domenica ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; SERINE PROTEINASE; TRANSFERRIN; TRANSMEMBRANE PROTEASE SERINE 6; UNCLASSIFIED DRUG; ANTIANEMIC AGENT; FERROUS ION; FERROUS SULFATE; MEMBRANE PROTEIN; TMPRSS6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FERRITIN BLOOD LEVEL; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; PRIORITY JOURNAL; THALASSEMIA; TREATMENT RESPONSE; ADOLESCENT; AGED; ANEMIA, IRON-DEFICIENCY; BLOOD; CASE CONTROL STUDY; CHILD; GENETICS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FERROUS COMPOUNDS; HEMATINICS; HEMOGLOBINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84925379852     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23929     Document Type: Article

References (31)

1. Stoltzfus RJ. Iron deficiency: Global prevalence and consequences. Food Nutr Bull 2003;24:S99-S103.
2. Beutler E. Hepcidin mimetics from microorganisms? A possible explanation for the effect of helicobacter pylori on iron homeostasis. Blood Cells Mol Dis 2007;38:54-55.
3. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: Molecular control of mammalian iron metabolism. Cell 2004;117:285-297.
4. Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int J Hematol 2002;7:219-228.
5. Nemeth E, Tuttle MS, Powelson J. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
6. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010;142:24-38.
7. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-539.
8. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008;320:1088-1092.
9. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40:569-571.
10. Velasco G, Cal S, Quesada V, et al. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 2002;277:37637-37646.
11. Silvestri L, Pagani A, Nai A, et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008;8:502-511.
12. Finberg KE, Whittlesey RL, Fleming MD, et al. Down-regulation of bmp/smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 2010;115:3817-3826.
13. Melis MA, Cau M, Congiu R, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93:1473-1479.
14. Guillem F, Kannengiesser C, Oudin C, et al. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. Hum Mutat 2012;33:1388-1396.
15. Silvestri L, Guillem F, Pagani A, et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood 2009;113:5605-5608.
16. Ramsay AJ, Quesada V, Sanchez M, et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum Mol Genet 2009;18:3673-3683.
17. De Falco L, Totaro F, Nai A, et al. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 2010;31:1390-1405.
18. Yilmaz-Keskin E, Sal E, de Falco L, et al. Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?. Turk J Pediatr 2013;55:479-484.
19. De Falco L, Sanchez M, Silvestri L, et al. Iron refractory iron deficiency anemia. Haematologica 2013;98:845-853.
20. An P, Wu Q, Wang H, et al. TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia. Hum Mol Genet 2012;21:2124-2131.
21. Benyamin B, Ferreira MA, Willemsen G, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009;41:1173-1175.
22. Tanaka T, Roy CN, Yao W, et al. A genome-wide association analysis of serum iron concentrations. Blood 2010;115:94-96.
23. Traglia M, Girelli D, Biino G, et al. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. J Med Genet 2011;48:629-634.
24. 1(C) levels via glycemic and nonglycemic pathways. Diabetes 2010;59:3229-3239.
25. Oexle K, Ried JS, Hicks AA, et al. Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum Mol Genet 2011;20:1042-1047.
26. Pellegrino RM, Coutinho M, D'Ascola D, et al. Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form. Br J Haematol 2012;158:668-672.
27. Benyamin B, Ferreira MA, Willemsen G, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009;41:1173-1175.
28. Chambers JC, Zhang W, Li Y, et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 2009;41:1170-1172.
29. Beutler E, Van Geet C, te Loo DM, et al. Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia. Blood Cells Mol Dis 2010;44:16-21.
30. Delbini P, Vaja V, Graziadei G, et al. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia. Br J Haematol 2010;151:281-284.
31. Nai A, Pagani A, Silvestri L, et al. TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. Blood 2011;118:4459-4462.